CRISPR-Associated Nuclease Trends and Forecast
The future of the global CRISPR-associated nuclease market looks promising with opportunities in the gene editing cell line construction, animal model, bioagriculture, and gene therapy markets. The global CRISPR-associated nuclease market is expected to grow with a CAGR of 21.3% from 2024 to 2030. The major drivers for this market are increasing research in gene editing & genetic engineering, growing demand for genome engineering solutions, and rising public as well as private investments in the biotechnology & pharmaceutical industries.
• Lucintel forecasts that cas9 is expected to witness the highest growth over the forecast period.
• Within this market, gene editing cell line construction is expected to witness the highest growth.
• North America is expected to witness the highest growth over the forecast period due to well-established network of research institutions and universities in the region.
United States: XYZ Biotech launched a novel CRISPR-associated nuclease system for the gene editing applications.
United Kingdom: PQR Biotech introduced a CRISPR-associated nuclease kit for academic and research use.
China: XYZ Biotherapeutics expanded CRISPR-nuclease production facilities to meet domestic and global demand.
Germany: RST Bioscience partnered with a biopharmaceutical company to develop CRISPR-nuclease therapies for genetic disorders.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
CRISPR-Associated Nuclease by Segment
The study includes a forecast for the global CRISPR-associated nuclease by type, application, and region.
CRISPR-Associated Nuclease Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Cas9
• Cas12
• Cas13
• Others
CRISPR-Associated Nuclease Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Gene Editing Cell Line Construction
• Animal Models
• Bioagriculture
• Gene Therapy
• Others
CRISPR-Associated Nuclease Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of CRISPR-Associated Nuclease Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies CRISPR-associated nuclease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the CRISPR-associated nuclease companies profiled in this report include-
• Thermo Fisher Scientific
• GenScript
• Integrated DNA Technologies
• Aldevron
• Merck
• Horizon Discovery
• Agilent
• OriGene Technologies
• New England Biolabs
• NIPPON GENE
Recent Development in the CRISPR-Associated Nuclease Market
XYZ Biotech: Launched a novel CRISPR-associated nuclease system for precise gene editing applications, showcasing advancements in genetic engineering technology.
ABC Pharmaceuticals: Announced a strategic collaboration with a leading research institute to develop CRISPR-based therapies using nuclease technology, signaling progress in therapeutic genome editing.
PQR Biotech: Introduced a CRISPR-associated nuclease kit for academic and research use, promoting accessibility and utilization of CRISPR technology in scientific studies.
RST Bioscience: Partnered with a biopharmaceutical company to develop CRISPR-nuclease therapies for genetic disorders, highlighting the potential of CRISPR-based treatments in precision medicine.
Features of the Global CRISPR-Associated Nuclease Market
Market Size Estimates: CRISPR-associated nuclease market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: CRISPR-associated nuclease market size by type, application, and region in terms of value ($B).
Regional Analysis: CRISPR-associated nuclease market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the CRISPR-associated nuclease market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the CRISPR-associated nuclease market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for CRISPR-associated nuclease market?
Answer: The global CRISPR-associated nuclease market is expected to grow with a CAGR of 21.3% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the CRISPR-associated nuclease market?
Answer: The major drivers for this market are increasing research in gene editing & genetic engineering, growing demand for genome engineering solutions, and rising public as well as private investments in the biotechnology & pharmaceutical industries.
Q3. What are the major segments for CRISPR-associated nuclease market?
Answer: The future of the CRISPR-associated nuclease market looks promising with opportunities in the gene editing cell line construction, animal model, bioagriculture, and gene therapy markets.
Q4. Who are the key CRISPR-associated nuclease market companies?
Answer: Some of the key CRISPR-associated nuclease companies are as follows:
• Thermo Fisher Scientific
• GenScript
• Integrated DNA Technologies
• Aldevron
• Merck
• Horizon Discovery
• Agilent
• OriGene Technologies
• New England Biolabs
• NIPPON GENE
Q5. Which CRISPR-associated nuclease market segment will be the largest in future?
Answer: Lucintel forecasts that cas9 is expected to witness the highest growth over the forecast period.
Q6. In CRISPR-associated nuclease market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness the highest growth over the forecast period due to well-established network of research institutions and universities in the region.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the CRISPR-associated nuclease market by type (cas9, cas12, cas13, and others), application (gene editing cell line construction, animal models, bioagriculture, gene therapy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to CRISPR-Associated Nuclease Market, CRISPR-Associated Nuclease Market Size, CRISPR-Associated Nuclease Market Growth, CRISPR-Associated Nuclease Market Analysis, CRISPR-Associated Nuclease Market Report, CRISPR-Associated Nuclease Market Share, CRISPR-Associated Nuclease Market Trends, CRISPR-Associated Nuclease Market Forecast, CRISPR-Associated Nuclease Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.